REPH insider trading

Recro Pharma, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
341
Last 90 days
0
Buys / sells
5% / 43%
Market cap

REPH insider activity at a glance

FilingIQ has scored 341 insider transactions for REPH since Dec 17, 2014. The most recent filing in our index is dated Mar 15, 2022.

Across the full history, 18 open-market purchases and 148 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on REPH insider trades is 49.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Frequently asked

How many insider trades does FilingIQ track for REPH?
FilingIQ tracks 341 Form 4 insider transactions for REPH (Recro Pharma, Inc.), covering filings from Dec 17, 2014 onwards. 0 of those were filed in the last 90 days.
Are REPH insiders net buyers or net sellers?
Across the full Form 4 history for REPH, 18 transactions (5%) were open-market purchases and 148 (43%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does REPH insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

Methodology & sources

Every REPH insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.